Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.38 -0.02 (-4.96%)
As of: Oct 22, 2026 · 10:27 AM EDT

Citius Pharmaceuticals (CTXR) Capital Expenditures (2021)

Updated

Citius Pharmaceuticals (CTXR) recorded Capital Expenditures of $39.99 million in fiscal Q4 2021 (quarter ended Sep 30, 2021).

Analysis

Citius Pharmaceuticals (CTXR) Capital Expenditures (2021) Analysis & Trends

For FY2021 (ended Sep 30, 2021), Citius Pharmaceuticals reported Capital Expenditures of $40 million.

  • Annual Capital Expenditures has a four-year compound annual growth rate of 1071.2% (FY2017 to FY2021).
  • Across earlier fiscal years, Capital Expenditures came in at $1,831 in FY2020 and $2,126 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,166.70 Bn 1,135.28 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 633.99 Bn 552.52 Bn 17.26 Bn 1.32 Bn
3 AbbVie 502.96 Bn 476.07 Bn 12.70 Bn 322.00 Mn
4 Merck 377.09 Bn 331.47 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 303.78 Bn 267.77 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 266.66 Bn 240.35 Bn 12.86 Bn 1.86 Bn
7 Amgen 241.39 Bn 196.79 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 140.00 Mn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 533.00 Mn
10 Citius Pharmaceuticals 9.91 Mn -23.66 Mn 1.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 40.00 Mn
API Access

Citius Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CTXR&period=max&api_key=YOUR_API_KEY